OPNT - Opiant Pharmaceuticals EPS beats by $0.19 beats on revenue August, 06 2020 04:17 PM Opiant Pharmaceuticals Inc. Opiant Pharmaceuticals (NASDAQ:OPNT): Q2 GAAP EPS of -$0.05 beats by $0.19.More news on: Opiant Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...